Wenhui Liu
Case Report: A case of severe hypotension induced by nimotuzumab in a nasopharyngeal carcinoma patient
Nimotuzumab, a humanized immunoglobulin G1 monoclonal antibody, is mainly used in combination with radiotherapy for the treatment of stage III/IV nasopharyngeal carcinoma (NPC) or locally advanced head and neck squamous-cell carcinoma (HNSCC) with posi…